Takeda Pharmaceutical Ltd ADR (TAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 4,016,916 | 3,981,711 | 4,527,545 | 4,222,214 | 4,170,720 |
| Cost of Goods | 1,156,780 | N/A | N/A | N/A | 1,162,410 |
| Gross Profit | 2,872,460 | 3,981,711 | 4,527,545 | 4,222,214 | 2,981,630 |
| Operating Expenses | 2,249,080 | 0 | 0 | 0 | 2,500,210 |
| Operating Income | 611,836 | 3,981,711 | 4,527,545 | 4,222,214 | 508,510 |
| Interest Expense | 0 | 0 | 0 | 0 | 7,330 |
| Other Income | -23,946 | 0 | 0 | 0 | 5,700 |
| Pre-tax Income | 587,890 | 3,981,711 | 4,527,545 | 4,222,214 | 506,880 |
| Income Tax | 251,650 | N/A | N/A | N/A | 206,800 |
| Net Income Continuous | 326,308 | -42,688 | 457,097 | 359,853 | 295,558 |
| Net Income | $326,308 | $-42,688 | $457,097 | $359,853 | $295,558 |
| EPS Basic Total Ops | 0.21 | -0.03 | 0.29 | 0.23 | 0.19 |
| EPS Basic Continuous Ops | 0.21 | -0.03 | 0.29 | 0.23 | 0.19 |
| EPS Diluted Total Ops | 0.21 | -0.03 | 0.29 | 0.23 | 0.19 |
| EPS Diluted Continuous Ops | 0.21 | -0.03 | 0.29 | 0.23 | 0.19 |
| EBITDA(a) | $611,836 | $3,981,711 | $4,527,545 | $4,222,214 | $508,510 |